Treatment of superior limbic keratoconjunctivitis by application of autologous serum.
about
Solid Platelet Rich Plasma in Corneal SurgeryThe ocular surface chemical burnsPathogenesis, clinical features and management of recurrent corneal erosionsUse of umbilical cord serum in ophthalmology.Evaluation of the efficacy of 50% autologous serum eye drops in different ocular surface pathologies.Adjunctive Therapies for Bacterial Keratitis.Limbal fibroblast conditioned media: a non-invasive treatment for limbal stem cell deficiency.Autologous Serum Eye Drops Accelerate Epithelial Healing After LASEK.Treatment of non-inflamed obstructive meibomian gland dysfunction by an infrared warm compression device.Autologous serum eye drops for ocular surface disorders.Keratolimbal allograft in corneal reconstruction.Albumin as a tear supplement in the treatment of severe dry eye.Limbitis secondary to autologous serum eye drops in a patient with atopic keratoconjunctivitis.Still confused about rose bengal?The Impact of Visual Guided Order Picking on Ocular Comfort, Ocular Surface and Tear FunctionComparison of corneal epitheliotrophic capacities among human platelet lysates and other blood derivativesLiquid nitrogen cryotherapy for surface eye disease (an AOS thesis)Autologous serum in the management of recalcitrant dry eye syndrome.Autologous serum eyedrops: literature review and implications for transfusion medicine specialists.Proposal of standardized guidelines for the production and quality control of autologous serum eye drops in Korea: based on a nationwide survey.Blood-derived topical therapy for ocular surface diseases.Current and Upcoming Therapies for Ocular Surface Chemical Injuries.Safety and efficacy of autologous serum eye drop for treatment of dry eyes in graft-versus-host disease.The efficacy of autologous serum eye drops for severe dry eye syndrome: a randomized double-blind crossover study.Fingerprick autologous blood: a novel treatment for dry eye syndrome.Topical treatment of ocular surface defects: comparison of the epitheliotrophic capacity of fresh frozen plasma and serum on corneal epithelial cells in an in vitro cell culture model.Effect of human autologous serum and fetal bovine serum on human corneal epithelial cell viability, migration and proliferation in vitro.Treating ocular surface disease: new agents in developmentA protocol for low contamination risk of autologous serum drops in the management of ocular surface disorders.Autologous serum eye drops for the treatment of severe dry eye in patients with chronic graft-versus-host disease.Topical application of autologous serum for the treatment of late-onset aqueous oozing or point-leak through filtering bleb.Serum components and clinical efficacies of autologous serum eye drops in dry eye patients with active and inactive Sjogren syndrome.Efficacy and safety of 0.1% lodoxamide for the long-term treatment of superior limbic keratoconjunctivitis.The corneal epitheliotrophic abilities of lyophilized powder form human platelet lysates.Current and emerging therapy of dry eye disease. Part A: pharmacological modalities
P2860
Q26749537-F22429FD-D46F-4646-BC45-752E8DB54BF9Q27023821-7D601F1E-8E8B-41D5-859D-F3C754118C14Q28261847-40ACF7EC-C475-4B84-BC0B-E879F3BEAC40Q30421187-143DA1D9-BAC7-4395-A61E-CC9CF8FB3C31Q30432843-7FD2C1A2-FB1D-4EEB-AE00-80C890096076Q33691959-E48E2EF9-83E8-4097-A506-65C733521946Q34664190-F3AA90A7-0AFD-4966-AE6A-6491B2B9F2A9Q35547147-DD85B1B4-7D27-45B9-9B40-599BDFE9BEFEQ35590257-5F9A6102-638A-4198-A3C9-04E3B055C96DQ35592577-C8658315-235A-407D-872B-4ECBD40D8141Q35740149-412A4BA5-481B-436F-83A4-3A488C115724Q35895180-E7ACD9DF-2D9F-4238-9420-901B7C065F78Q35952534-AE84FBBF-60C9-4C2B-AF33-2CAEBE88081DQ35980008-44DA8FDB-709F-4B27-923A-487A887DC2BFQ36055391-104D36AA-30A5-4A56-B32B-AE7DC1524AC4Q36267618-5E82D618-C84D-47BB-82B3-4AE8CCC39371Q37106301-67A39469-8BA2-4182-8EA2-53EB8B3D77F7Q37114042-5FA0636C-5899-4180-887E-4BC49F0CAE20Q37137885-BF281450-540E-405B-99C2-260E79240797Q38195094-F412A6F7-8E71-46C4-B1FD-76E154911F61Q38547921-F75FE7C2-5B08-42DB-B09F-DFFCB01F4DF0Q38819339-8DF67040-1ADE-40D3-B328-1F2E205E4B64Q38887004-98A034F3-A691-4907-9C0C-2D67341D7D45Q39211271-1BB820AC-8801-452F-8916-2E9A046DB5F3Q39378640-1AFD1F9F-472B-4372-8C22-EDF8C990F3FAQ40429535-D4D75D8C-EF86-4964-9DB7-8AF30495B24DQ41045866-EE67814A-DABA-4F84-9C0B-4FD3184C717EQ42729437-651D4DBA-C085-46B9-B599-343E68BFAFE5Q43007902-F126713B-79D4-4787-8112-E89942708096Q44401535-005D2E33-7AD0-4022-84E1-66EED5E09948Q44978884-AF7D90B7-B6C0-4357-BC0F-F40D57340D2BQ47203561-58A774CD-95CC-49BE-B9B2-3404D8AD325EQ48295827-D9F8B920-C4A9-473E-9FE8-11CF32D8FD3DQ52652182-CA17DBB5-7F70-417B-8E86-A38C5E0FB669Q57378488-DE9D5F89-49A1-4285-8B06-C6FD5EC10E59
P2860
Treatment of superior limbic keratoconjunctivitis by application of autologous serum.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh-hant
name
Treatment of superior limbic keratoconjunctivitis by application of autologous serum.
@en
Treatment of superior limbic keratoconjunctivitis by application of autologous serum.
@nl
type
label
Treatment of superior limbic keratoconjunctivitis by application of autologous serum.
@en
Treatment of superior limbic keratoconjunctivitis by application of autologous serum.
@nl
prefLabel
Treatment of superior limbic keratoconjunctivitis by application of autologous serum.
@en
Treatment of superior limbic keratoconjunctivitis by application of autologous serum.
@nl
P2093
P1433
P1476
Treatment of superior limbic keratoconjunctivitis by application of autologous serum.
@en
P2093
P304
P356
10.1097/00003226-200111000-00006
P577
2001-11-01T00:00:00Z